Clinical Trial Update: Higher Frequency Zoledronic Acid in the Treatment of Multiple Myeloma [Phase 2]

View source ↗

Summary

A Phase 2 trial assessed higher-frequency dosing of zoledronic acid in patients with multiple myeloma. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Gleneagles Hospital | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED